Parallel Bio

We are a drug discovery company developing a new generation of therapeutics that embrace the complexity of disease. Currently available approaches for creating drugs work on the principle of finding one drug-one protein 'magic bullets'. However, diseases such as cancer and autoimmunity are often the result of several dysregulated proteins across many distinct biological pathways. We are building a computational-experimental platform to design therapeutics that can target several disease-causing

shared extracted concept terms: computational, drug; shared product terms: drug, discovery, complexity, disease; shared product theme: health and clinical care; same category: Healthcare; shared affiliation: Y Combinator

Numerion Labs is an AI-native company accelerating the discovery of life-saving medicines through the development and use of cutting-edge machine learning algorithms. The company unites computational chemistry, structural biology, and medicinal chemistry to pioneer the next generation of AI-driven drug discovery platforms.

shared extracted concept terms: biology, computational, drug; shared product terms: discovery, development, computational, biology; shared affiliation: Y Combinator

CellType is building an agentic drug company. AI agents that run the full drug discovery pipeline on top of biological foundation models that simulate human biology. Our core technology, developed with Google DeepMind, has already discovered and validated a new cancer treatment signal. We’re working with Top 10 pharma.

shared extracted concepts: human biology; shared product terms: drug, discovery, pipeline, biological; shared affiliation: Y Combinator

Origami Therapeutics, Inc. is a biotech company developing novel protein degraders with potential to delay or halt disease progression by eliminating toxic proteins from the body. Our drug discovery platform leverages our proprietary human disease models developed to select the small molecules with the best chance of clinical success. Our first indication is Huntington’s disease, a debilitating, progressive and ultimately fatal disorder caused by a genetic mutation. We have already identified sm

shared extracted concept terms: drug, human, disease; shared product terms: disease, drug, discovery, human; shared product theme: health and clinical care; shared affiliation: Y Combinator

Ditto Bio discovers drugs for autoimmune diseases by harnessing parasite biology. Viruses, ticks, and worms have experimented over millions of years to create proteins that control the human immune system. We use AI to identify these proteins and engineer them into next-generation autoimmune therapies. Our team is three PhD scientists from UCSF, UCSD, and UC Berkeley who have worked together for 3+ years in biotech. We have deep expertise in parasite biology, computational biology, and software

shared extracted concept terms: computational, biology; shared product terms: bio, drug, disease, biology; shared affiliation: Y Combinator

Discovering the atlas of disease biology using virtual cells.

shared extracted concept terms: disease, biology; shared product terms: disease, biology; shared affiliation: Y Combinator